Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials by Chengxin Luo, Chengxin Luo, Xiangtao Huang, Xiangtao Huang, Ling Wei, Ling Wei, Guixian Wu, Guixian Wu, Yarui Huang, Yarui Huang, Yaqun Ding, Yaqun Ding, Zhen Huang, Zhen Huang, Jieping Chen, Jieping Chen, Xi Li, Yunding Zou, Yunding Zou, Shuangnian Xu, Shuangnian Xu

Get full text

COVID‐19 metabolism: Mechanisms and therapeutic targets by Tianshi Wang, Ying Cao, Haiyan Zhang, Zihao Wang, Cheuk Him Man, Yunfan Yang, Lingchao Chen, Shuangnian Xu, Xiaojing Yan, Quan Zheng, Yi‐Ping Wang

Get full text

Overcoming adaptive resistance in AML by synergistically targeting FOXO3A-GNG7-mTOR axis with FOXO3A inhibitor Gardenoside and rapamycin by Zhe Chen, Qian Guo, Shichen Huang, Lei Li, Feng Wu, Zhilong Liu, Zhigang Li, Tao Chen, Guanbin Song, Shuangnian Xu, Jieping Chen, Yu Hou

Get full text

Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China by Junnan Li, Li Pei, Simin Liang, Shuangnian Xu, Yi Wang, Xiao Wang, Yi Liao, Qian Zhan, Wei Cheng, Zesong Yang, Xiaoqiong Tang, Hongbin Zhang, Qing Xiao, Jianbin Chen, Lin Liu, Li Wang

Get full text